Forian Inc. (Nasdaq: FORA) announced today the successful completion of its previously announced cash tender offer and merger, taking the company private. The transaction, valued at $2.17 per share in cash, was completed on May 15, 2026, following the expiration of the tender offer on May 14, 2026.
The tender offer was made by Bravo Merger Sub, Inc., a wholly owned subsidiary of 2025 Acquisition Company, LLC. As of the expiration date, 6,444,415 shares were validly tendered, which, combined with the 21,887,631 shares already owned by the buyer parties—representing approximately 70% of outstanding shares—satisfied the minimum condition. All conditions having been met, Merger Sub accepted the shares and promptly merged with and into Forian, with Forian surviving as a wholly owned subsidiary of Parent.
This move marks the end of Forian's public trading. The company's common stock will cease trading on the Nasdaq Stock Market prior to market open on May 15, 2026. Forian has requested that Nasdaq file a notification of delisting on Form 25 with the U.S. Securities and Exchange Commission (SEC) and intends to file a Form 15 to terminate its registration and suspend reporting obligations under the Securities Exchange Act of 1934.
The transaction carries significant implications for shareholders, who will receive $2.17 per share, and for the company itself, which will now operate as a private entity. Forian, a provider of data analytics and information solutions, specializes in healthcare data management and analytics for life sciences, healthcare payers, providers, and financial services. By going private, the company may gain flexibility in its operations without the reporting requirements and market pressures of being publicly traded.
For more information about Forian, visit the company's website at www.forian.com. The transaction highlights a trend of companies opting for privatization to streamline decision-making and focus on long-term strategies away from public market scrutiny.
This press release contains forward-looking statements regarding risks and uncertainties. Factors that could affect actual results are detailed in Forian's filings with the SEC, including its most recent Annual Report on Form 10-K. The company undertakes no obligation to update these statements.
